Founded in 1989, Jafron Biomedical is a global provider of blood purification technology, products and services. With a market value of $7 billion, the company has three branches, 11 subsidiaries and one subsidiary.
Jafron has been diligently researching and developing, manufacturing and selling blood purification products mainly based on adsorption mechanism for decades, and has been providing high-quality services in the treatment of ESRD, acute poisoning, liver diseases, immune disorders, etc. worldwide. The company has established 183 offices in China and five global service centers, including in Vietnam, Europe, South America, and a professional team of more than 1,100 employees. With more than 20 years of clinical experience, the company’s flagship product is the “HA Series Disposable Hemoperfusion Cartridge”, which has been used in more than 8,000 key hospitals in 80 countries and has 5 million clinical cases annually.
As a global provider of absorption-based therapies, Jafron is active in all aspects of disease, from research and development of new treatments to product manufacturing. The company is continuously striving to explore new medical fields to save patients’ lives, improve their quality of life, and realize the vision of “Health Technology for a Better World.”
